These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12176545)

  • 1. Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
    Citterio F; Rigotti P; Scatà MC; Romagnoli J; Baldan N; Marchini F; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1707-8. PubMed ID: 12176545
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.
    Sola E; Alférez MJ; Cabello M; Burgos D; González Molina M
    Transplant Proc; 2002 Aug; 34(5):1689-90. PubMed ID: 12176537
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.
    Alarcón-Zurita A; Munar MA; Losada P; Morey A; Martinez J; de la Prada FJ; Marco J
    Transplant Proc; 2002 Feb; 34(1):118-9. PubMed ID: 11959216
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.
    Facundo C; Diaz JM; Guirado L; Duran F; Herreros MA; Diaz M; Sola R
    Transplant Proc; 2002 Feb; 34(1):98. PubMed ID: 11959203
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience.
    Beaunoyer M; Busque S; St-Louis G; Smeesters C; Pâquet M; Lallier M; Fugère J; Girardin C; Hébert MJ; Daloze P
    Transplant Proc; 2002 Aug; 34(5):1694-5. PubMed ID: 12176540
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J
    Transplant Proc; 1999; 31(1-2):276-7. PubMed ID: 10083106
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
    Grewal HP; Thistlethwaite JR; Loss GE; Bruce DS; Siegel CT; Cronin DC; Newell KA; Millis JM; Woodle ES
    Transplant Proc; 1998 Jun; 30(4):1378-9. PubMed ID: 9636558
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
    Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical study of FK 506 in renal transplant recipients.
    Youhua Z; Zhinlian M; Liming W
    Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
    [No Abstract]   [Full Text] [Related]  

  • 13. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.
    Boots JM; Christiaans MH; van Duijnhoven EM; van Suylen RJ; van Hooff JP
    Transplant Proc; 2002 Aug; 34(5):1698-9. PubMed ID: 12176542
    [No Abstract]   [Full Text] [Related]  

  • 15. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ
    Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.
    Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P;
    Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of everolimus and tacrolimus in kidney transplant patients with intolerance to mycophenolate mofetil/mycophenolic acid.
    Balda S; Inza A; Odriozola N; Zárraga S; García-Erauskin G; Lampreabe I
    Transplant Proc; 2009; 41(6):2095-8. PubMed ID: 19715841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E; Soluch L; Cieciura T; Lewandowska D; Durlik M; Shaibani B; Serafinowicz A; Szmidt J; Rowiński W; Lao M
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
    Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
    Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.